Patterns of sexual and injecting risk behaviours in French intravenous drug users not reporting HIV and hepatitis C virus seropositivities

Addiction

Volumn 93, Issue 11, 1998, Pages 1657-1668

  Vidal Trécan, Gwenaëlle ^a,b   Coste, Joel ^a   Varescon Pousson, Isabelle ^a   Reboul Marty, Jeanne ^a   Christoforov, Boyan ^a   Boissonnas, Alain ^a  

^a Univ René Descartes ^*  (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; ALCOHOL ABUSE; ARTICLE; CONDOM; EDUCATION; FEMALE; FRANCE; HEPATITIS C; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PROSTITUTION; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SEROLOGY; SEXUAL BEHAVIOR; SOCIAL STATUS;

EID: 0031786401     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1360-0443.1998.931116574.x     Document Type: Article

References (63)

1. ALCABES, P., VLAHOV, D. & ANTHONY, J. C. (1992) Correlates of human immunodeficiency virus infection in intravenous drug users: are treatment-programme samples misleading? British Journal of Addiction, 8, 47-54.
2. BATTJES, R. J., PICKENS, R. W., AMSEL, Z. & BROWN JR, L. S. (1990) Heterosexual transmission of human immunodeficiency virus among intravenous drug users, Journal of Infectious Diseases, 162, 1007-1011.
3. CHAISSON, R. E., BACCHETTI, P., OSMOND, D., BRODIE, B., SANDE, M. A. & MOSS, A. R. (1989) Cocaine use and HIV infection in intravenous drug users in San Francisco, Journal of the American Medical Association, 261, 561-565.
4. CHITWOOD, D. D., GRIFFIN, D. K. & COMERFORD, M. et al. (1995) Risk factors for HIV-1 seroconversion among injection drug users: a case-control study, American Journal of Public Health, 85, 1538-1542.
5. GARFEIN, R. S., VLAHOV, D., GALAI, N., DOHERTY, M. C. & NELSON, K. E. (1996) Viral infection in short-term injection drug users: the prevalence of hepatitis C, hepatitis B, human immunodeficiency and human T-lymphotropic viruses, American Journal of Public Health, 86, 655-661.
6. GIRARDI, E., ZACCARELLI, M., TOSSINI, G., PURO, V., NARCISO, P. & VISCO, G. (1990) Hepatitis C virus infection in intravenous drug users prevalence and risk factors, Scandinavian Journal of Infectious Diseases, 22, 751-752.
7. LIMA, E. S., FRIEDMAN, S. R. & BASTOS, F. I. et al. (1994) Risk factors for HIV-1 seroprevalence among drugs injectors in the cocaine-using environment of Rio de Janeiro, Addiction, 89, 689-698.
8. MARMOR, M., DES JARLAIS, D. C. & COHEN H. et al. (1987) Risk factors for infection with immunodeficiency virus among intravenous drug abusers in New York City, AIDS, 1, 39-44.
9. SCHOENBAUM, E. E., HARTEL, D. & SELWYN, P. A. et al. (1989) Risk factors for immunodeficiency virus infection in intravenous drug users, New England Journal of Medicine, 321, 874-879.
10. STARK, K., MÜLLER, R., WIRTH, D., BIENZLE, U., PAULI, G. & GUGGENMOOS-HOLZMANN, I. (1995) Determinants of HIV infection and recent risk behaviour among injecting drug users in Berlin by site of recruitment, Addiction, 90, 1367-1367.
11. THOMAS, D. L., VLAHOV, D. & SOLOMON, L. et al. (1995) Correlates of hepatitis C virus infections among injection drug users, Medicine, 74, 212-219.
12. VLAHOV, D., MUNOZ, A., ANTHONY, J. C., COHN, S., CELENTANO, D. D. & NELSON, K. E. (1990) Association of drug injection patterns with human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland, American Journal of Epidemiology, 132, 847-856.
13. HARRIS, R. E., LANDGROD, J., HEBERT, J. R., LOWINSON, J., ZANG, E. & WYNDER, E. L. (1990) Changes in AIDS risk behavior among intravenous drug abusers in New York City, New York State Journal of Medicine, 90, 123-126.
14. VAN AMEIJDEN, E. J. C., VAN DEN HOEK, A. A. R. & COUTINHO, R. A. (1996) Large decline in sexual risk behavior with noncommercial partners among heterosexual injection drug users in Amsterdam, American Journal of Epidemiology, 144, 772-781.
15. DES JARLAIS, D. C., MARMOR, M. & PAONE, D. et al. (1996) HIV incidence among injecting drug users in New York City syringe-exchange programmes, Lancet, 987-991.
16. ASTEMBORSKI, J., VLAHOV, D., WARREN, D., SOLOMON, L. & NELSON, K. E. (1994) The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users, American Journal of Public Health, 84, 382-387.
17. EYSTER, M. E., ALTER, H. J., ALEDORT, L. M., QUAN, S., HATZAKIS, A. & GOEDERT, J. J. (1991) Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV), Annals of Internal Medicine, 115, 764-768.
18. SALVAGGIO, A., CONTI, M. & ALBANO, A. et al. (1993) Sexual transmission of hepatitis C virus and HIV-1 infection in female injection drug users, European Journal of Epidemiology, 9, 279-284.
19. BAKER, A., KOCHAN, N., DIXON, J., WODAK, A. & HEATHER, N. (1994) Drug use and HIV risk-taking behavior among injecting drugs users not currently in treatment in Sydney, Australia, Drug and Alcohol Dependence, 34, 155-160.
20. DONOGHOE, M. C. (1992) Sex, HIV and the injecting drug user, British Journal of Addiction, 87, 405-416.
21. FEUCHT, E., STEPHENS, R. C. & ROMAN, S. W. (1990) The sexual behavior of intravenous drug users: assessing the risk of sexual transmission of HIV, Journal of Drug Issues, 20, 195-213.
22. BATTJES, R. J., LEUKEFELD, C. G. & PICKHNS, R. W. (1992) Age at first injection and HIV risk among intravenous drug users, American Journal of Drug and Alcohol Abuse, 18, 263-273.
23. DARKE, S., BAKER, A., DIXON, J., WODAK, A. & HEATHER, N. (1992) Drug use and HIV risk-taking behaviour among clients in methadone maintenance treatment, Drug and Alcohol Dependence, 29, 263-268.
24. DARKE, S., HALL, W., DIXON, J. & CARLESS, J. (1990) Drug use, injecting practices and sexual behaviour of opioid users in Sydney, Australia, British Journal of Addiction, 85, 1603-1609.
25. KLEE, H., FAUGIER, J., HAYES, C., BOULTON, T. & MORRIS, J. (1990) Sexual partners of injecting drug users: the risk of HIV infection, British Journal of Addiction, 85, 413-418.
26. LEWIS, D. K. & WATTERS, J. K. (1991) Sexual risk behavior among heterosexual intravenous drug users: ethnic and gender variations, AIDS, 5, 77-83.
27. LIEBMAN, J., MULIA, N. & MCILVAINE, D. (1992) Risk behavior for HIV infection of intravenous drug users and their sexual partners recruited from street settings in Philadelphia, Journal of Drug Issues, 22, 867-884.
28. LOXLEY, W. M., MARSH, A. M., HAWKS, D. V. & QUIGLEY, A. J. (1992) HIV risk behavior among injecting drug users in Perth: the Australian National AIDS and injecting drug use study, Medical Journal of Australia, 156, 687-692.
29. MAGURA, S., SHAPIRO, J., SIDDIQI, Q., LIPTON, D. S. & MARION, I. (1990) Variables influencing condom use among intravenous drug users, American Journal of Public Health, 80, 82-84.
30. MCCUSKER, J., KOBLIN, B., LEWIS, B. F. & SULLIVAN, J. (1990) Demographic characteristics, risk behaviors, and HIV seroprevalence among intravenous drug users by site of contact: results from a community-wide HIV surveillance project, American Journal of Public Health, 80, 1062-1067.
31. MCDONALD, C., LOXLEY, W. & MARSH, A. (1994) A bridge too near? Injecting drug users' sexual behavior, AIDS Care, 6, 317-326.
32. PRADIER, C., BARDEAU, J. J. & SIMON, P. J. et al. (1993) Infection à VIH. Comportements à risque chez les toxicomanes par voie veineuse. Expérience dans les Alpes-Maritimes [HIV infection. High risk behaviours among drug users in Southeast France], La Presse Medicale, 22, 1347-1351.
33. RHODES, T. J., DONOGHOE, M. C., HUNTER, G. M. & STIMSON, G. V. (1993) Continued risk behaviour among HIV positive drug injectors in London: implications for intervention, Addiction, 88, 1553-1560.
34. ROSS, M. W., STOWE, A., WODAK, A., MILLER, M. E. & GOLD, J. (1993) A comparison of drug use and HIV infection risk behavior between injecting drug users currently in treatment, previously in treatment, and never in treatment, Journal of Acquired Immune Deficiency Syndrome, 6, 518-528.
35. ROTILY, M., GALINIER-PUJOL, A. & VERNAY-VAISSE, C. (1995) Risk behaviours of inmates in south-eastern France, AIDS Care, 7, S89-S93.
36. SASSE, H., SALMASO, S., CONTI, S., REZZA, G. & THE FIRST MULTICENTRE STUDY GROUP (1991) Sexual lifestyles in injecting drug users in Italy: potential for HIV infection transmission, British Journal of Addiction, 86, 1083-1089.
37. VAN AMEIJDEN, E. J. C., VAN DEN HOEK, A. A. R. & COUTINHO, R. A. (1994) Injecting risk behavior among drug users in Amsterdam, 1986 to 1992 and its relationship to AIDS prevention programs, American Journal of Public Health, 84, 275-281.
38. WATKINS, K. E., METZGER, D., WOODY, G. & MCLELLAN, A. T. (1993) Determinants of condom use among intravenous drug users, AIDS, 7, 719-723.
39. WENGER, N. S., LINN, L. S., EPSTEIN, M. & SHAPIRO, M. F. (1991) Reduction of high risk sexual behavior among heterosexuals undergoing HIV antibody testing: a randomized clinical trial, American Journal of Public Health, 8, 1580-1585.
40. DESENCLOS, J. C., PAPAEVANGELOU, G. & ANCELLE-PARK, R. FOR THE COMMUNITY STUDY GROUP ON HIV IN INJECTING DRUG USERS (1993) Knowledge of HIV serostatus and preventive behaviour among European injecting drug users, AIDS, 7, 1371-1377.
41. BOISSONNAS, A., VIDAL-TRÉCAN, G., COSTE, J., VARESCON-POUSSON, I. & REBOUL-MARTY, J. (1996) Les Comportements à Risque des Toxicomanes [Risk-Behaviours of Drug Addicts] (Sèvres, Editions médicales et scientifiques EDK).
42. VIDAL-TRÉCAN, G., COSTE, J., COEURET, M., DELAMARE, N., VARESCON-POUSSON, I. & BOISSONNAS, A. (1998) Les comportements à risque des usagers de drogues par voie intraveineuse: les femmes prennent elles plus de risque de transmission des virus VIH et VHC? [Risk behaviours of intravenous drug users: are females taking more risks of HIV and HCV transmission?], Revue d'Epidemiologie cl de Santé publique, 46, 193-204.
43. ACSF INVESTIGATORS (1992) AIDS and sexual behavior in France, Nature, 360, 407-409.
44. SPIRA, A., BAJOS, N. ET LE GROUPE ACSF (1993) Les Comportements Sexuels en Prance [Sexual behaviours in France] (Paris, La Documentation Française).
45. KLEE, H., FAUGIER, J., HAYES, C., BOULTON, T. & MORRIS, J. (1990) Factors associated with risk behaviour among injecting drug users, AIDS Care, 2, 133-145.
46. CRISP, B. R., BARBER, J. G., ROSS, M. W., WODAK, A., GOLD, J. & MILLER, M. E. (1993) Injecting drugs users and HIV/AIDS: risk behaviours and risk perception, Drug and Alcohol Dependence, 33, 73-80.
47. DARKE, S., HALL, W., HEATHER, N., WARD, J. & WODAK, A. (1991) The reliability and validity of a scale to measure HlV risk-taking behaviour among intravenous drug users, AIDS, 5, 181-185.
48. SAXON, A. J. & CALSYN, D. A. (1992) Alcohol use and high-risk behavior by intravenous drug users in an AIDS education paradigm, Journal of Studies on Alcohol, 53, 611-618.
49. MANDELL, W., VLAHOV, D., LATKIN, C., OZIEMKOWSKA, M. & COHN, S. (1994) Correlates of needle sharing among injection drug users, American Journal of Public Health, 84, 920-923.
50. MAGURA, S., GROSSMAN, J. I. & LIPTON, D. S. et al. (1989) Determinants of needle sharing among intravenous drug users, American Journal of Public Health, 79, 459-462.
51. KANG, S. Y. & DE LEON, G. (1993) Correlates of drug injection behaviors among methadone outpatients, American Journal of Drug and Alcohol Abuse, 19, 107-118.
52. HADDEN, W. C. (1996) Annotation: the use of educational attainment as an indicator of socioeconomic position, American Journal of Public Health, 86, 1525-1526.
53. VANICHSENI, S., CHOOPANYA, K. & DES JAKLAIS, D. C. et al. (1992) HIV testing and sexual behavior among intravenous drug users in Bangkok, Thailand, Journal of Acquired Immune Deficiency Syndrome, 5, 1119-1123.
54. HELAL, H., MOMAS, I., PRÉTET, S., MARSAI., L. & POINSARD, R. (1995) HIV prevalence and risk behaviour among intravenous drug users attending HIV counseling and testing centres in Paris, Addiction, 90, 1627-1633.
55. HIGGINS, D. L., GALAVOTTI, C. & O'REILLY, K. R. et al. (1991) Evidence for the effects of HIV antibody counseling and testing on risk behaviors, Journal of the American Medical Association, 266, 2419-2429.
56. STARK, K., MULLER, R., BIENZLE, U. & GUGGENMOOS-HOLZMANN, I. (1996) Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin, AIDS, 10, 311-317.
57. ANONYMOUS (1994) Knowledge and practices among injecting-drug users of bleach use for equipment disinfection - New York City, 1993, Morbidity Mortality Weekly Report, 43, 439-445.
58. GLEGHORN, A. A., DOHERTY, M. C., VLAHOV, D., CELENTANO, D. D. & JONES, T. S. (1994) Inadequate bleach contact times during syringe cleaning among injection drug users, Journal of Acquired Immune Deficiency Syndrome, 7, 767-772.
59. JAMNER, M. S., CORBY, N. H. & WOLITSKI, R. J. (1996) Bleaching injection equipment: influencing factors among IDUs who share, Subnance Use and Misuse, 31, 1973-1993.
60. FACY, V. (1995) Abords épidémiologiques de la toxicomanie: morbidité et évaluation du système de soins [Epidemiological approach of addiction: morbidity and evaluation of health care organization], Revue du Praticien, 45, 1345-1350.
61. SAMUELS, J. F., VLAHOV, D., ANTHONY, J. C. & CHAISSON, R. E. (1992) Measurement of HIV risk behaviors among intravenous drug users, British Journal of Addiction, 87, 417-428.
62. MCELRATH, K., CHITWOOD, D. D., GRIFFIN, D. K. & COMERFORD, M. (1994) The consistency of self-reported HIV risk behavior among injection drug users, American Journal of Public Health, 84, 1965-1970.
63. LATKIN, C. A., VLAHOV, D. & ANTHONY, J. C. (1993) Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users, Addiction, 88, 517-526.